Torque Appoints John Hohneker, MD, to Board of Directors and Marcela Maus, MD, PhD, to Scientific Advisory Board

CAMBRIDGE, Mass., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Torque, an immuno-oncology company developing Deep Primed™ cell therapeutics with pharmacologic control to drive a full immune response within the tumor microenvironment, announ... Biopharmaceuticals, Oncology, Personnel Torque, Deep Primed, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news